SCYNEXIS, Inc. And Medicines for Malaria Venture (MMV) Sign HEOS(R) Agreement

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--SCYNEXIS, Inc. and Medicines for Malaria Venture (MMV) announced today that they have signed an agreement giving MMV access to SCYNEXIS’ proprietary HEOS® drug discovery software platform for use in the organization’s anti-malarial research projects.

Back to news